Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Frequent budget adjustments help you respond to income shifts and spending surprises. This intro guides quick, practical tweaks for staying on track.
26,559 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
The U.S. government has halted Anthropic's Fable 5 and Mythos 5, citing a security vulnerability. The move shakes fin...
Value seekers are spotting a window: a well-known tech name trading at a discount as AI momentum roars. Here’s how to...
Two real estate ETFs take opposite paths: one spreads bets worldwide, the other bets on the U.S. market. Learn how HA...
An in-depth look at Warner Bros. Discovery (WBD) earnings, how its streaming ambitions intersect with legacy TV, and ...
FedEx recently spun off its FedEx Freight unit, creating two focused companies. This article explains what that move ...
A fast IPO run can leave investors excited but unsure what comes next. We break down whether this stock soared 123% s...
Newmont, the largest gold miner, is facing a sell-off that’s drawing attention from traders and long-term investors a...
Investing in Broadcom means weighing powerful data-center demand against semiconductor cycles. This guide breaks down...
Ondas (ONDS) reports its Q1 2026 results, revealing early signs of progress and persistent headwinds. This guide brea...
Two popular ETFs vie for attention in growth-heavy markets. This guide breaks down what each fund owns, how they beha...
When a top executive sells a large block of stock, investors often wonder about the meaning behind the move. This gui...